Overview

Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects

Status:
Unknown status
Trial end date:
2021-06-19
Target enrollment:
Participant gender:
Summary
The overall objective of this study is to compare the overall pattern of [18F]APN-1607 uptake in subjects with MDAD, subjects with AD dementia, and healthy subjects.
Phase:
Phase 2
Details
Lead Sponsor:
Aprinoia Therapeutics Inc.